I am a
Home I AM A Search Login

Papers of the Week


Papers: 16 May 2020 - 22 May 2020


Human Studies, Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2020 May 18


Eur J Neurol

Evaluation of the concomitant use of oral preventive treatments and OnabotulinumtoxinA in chronic migraine: the PREVENBOX study.

Authors

Alpuente A, Gallardo V J, Torres-Ferrús M, Santos-Lasaosa S, Guerrero Á, Laínez J M, Viguera J, Gago-Veiga A, Irimia P, Del Río M S, Pozo-Rosich P
Eur J Neurol. 2020 May 18.
PMID: 32421912.

Abstract

OnabotulinumtoxinA is an effective preventive treatment for chronic migraine. In chronic migraine, besides a reduction in headache frequency, a decreased reliance on oral prophylactics is also indicative of treatment effectiveness. This study aimed to quantify the change in the use of oral prophylactics after treatment with onabotulinumtoxinA in patients with chronic migraine.